Todd L. Cecil
Todd L. Cecil
Todd L. Cecil
Vice-President,
Compendial Science,
United States Pharmacopeia
Todd L. Cecil, PhD, is the vice-president of compendial science at USP. He has been with the organization since 1993 and has held the following positions: director of noncomplex actives and general policies and requirements; project manager of new monograph development project; scientist; and chemist III.
Cecil is presently a member of the American Association of Pharmaceutical Scientists (AAPS) and ACS. While at AAPS, he has held the positions of secretary treasurer, vice-chair, chair-elect, chair, and past-chair of the APQ Section of AAPS; chair APQ Workshop Committee; and AAPS APQ lead paper screener. He is the author of seven publications and has made more than 60 national and international presentations.
He holds a BS in chemistry from the University of Iowa and a PhD in analytical chemistry from Virginia Commonwealth University.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Understanding the Variability in Bioburden Test Results in Biomanufacturing
May 7th 2025This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.
